As mentioned in the introduction, there are certain surface modifications that can be implemented on the chitosan nanoparticles for specific targeting of brain tumors, such as modifying with tumor-targeting peptides, such as transferrin and chlorotoxin, to target brain tumors with over-expression of TfR or Matrix Metalloproteinase-2 (MMP-2). This evidence concerns the gene TFRC and brain neoplasm.